- Home
- WASH vs FULC Comparison
WASH vs FULC Comparison
Compare WASH & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WASH | FULC |
|---|---|---|
| Founded | 1800 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 682.2M | 718.4M |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | WASH | FULC |
|---|---|---|
| Price | $34.39 | $8.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $31.25 | $16.38 |
| AVG Volume (30 Days) | 104.3K | ★ 956.3K |
| Earning Date | 04-29-2026 | 05-19-2026 |
| Dividend Yield | ★ 6.51% | N/A |
| EPS Growth | ★ 266.26 | N/A |
| EPS | ★ 2.71 | N/A |
| Revenue | ★ $229,048,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.19 | N/A |
| P/E Ratio | $12.70 | ★ N/A |
| Revenue Growth | ★ 127.57 | N/A |
| 52 Week Low | $24.97 | $2.32 |
| 52 Week High | $37.08 | $15.74 |
Technical Indicators
Market Signals| Indicator | WASH | FULC |
|---|---|---|
| Relative Strength Index (RSI) | 51.59 | 37.55 |
| Support Level | $26.60 | $6.33 |
| Resistance Level | $37.08 | $8.50 |
| Average True Range (ATR) | 1.24 | 0.84 |
| MACD | -0.34 | -0.26 |
| Stochastic Oscillator | 51.66 | 18.40 |
Price Performance
Historical ComparisonAbout WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.